Cross sectional comparisons suggested significant differences in the serum concentrations of VEGF-D between presenting groups (i.e. ischaemic stroke, TIA, haemorrhagic stroke and stroke mimics), and serum angpt-2 across TOAST categories (Supplements 5 and 6). This evidence concerns the gene VEGFD and ischemic stroke.